These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8081861)

  • 1. Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-ones.
    Barrish JC; Spergel SH; Moreland S; Grover G; Hedberg SA; Pudzianowski AT; Gougoutas JZ; Malley MF
    Bioorg Med Chem; 1993 Oct; 1(4):309-25. PubMed ID: 8081861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.
    Kimball SD; Hunt JT; Barrish JC; Das J; Floyd DM; Lago MW; Lee VG; Spergel SH; Moreland S; Hedberg SA
    Bioorg Med Chem; 1993 Oct; 1(4):285-307. PubMed ID: 8081860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.
    Floyd DM; Kimball SD; Krapcho J; Das J; Turk CF; Moquin RV; Lago MW; Duff KJ; Lee VG; White RE
    J Med Chem; 1992 Feb; 35(4):756-72. PubMed ID: 1542102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.
    Kimball SD; Floyd DM; Das J; Hunt JT; Krapcho J; Rovnyak G; Duff KJ; Lee VG; Moquin RV; Turk CF
    J Med Chem; 1992 Feb; 35(4):780-93. PubMed ID: 1311765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
    Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
    J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
    Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
    J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.
    Das J; Floyd DM; Kimball SD; Duff KJ; Vu TC; Lago MW; Moquin RV; Lee VG; Gougoutas JZ; Malley MF
    J Med Chem; 1992 Feb; 35(4):773-80. PubMed ID: 1542103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers.
    Mehanna AS; Kim JY
    Bioorg Med Chem; 2005 Jul; 13(13):4323-31. PubMed ID: 15927838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and Ca2+ antagonistic activity of diltiazem metabolites.
    Li R; Farmer PS; Xie M; Quilliam MA; Pleasance S; Howlett SE; Yeung PK
    J Med Chem; 1992 Aug; 35(17):3246-53. PubMed ID: 1507210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling study of diltiazem mimics at L-type calcium channels.
    Schleifer KJ; Tot E
    Pharm Res; 1999 Oct; 16(10):1506-13. PubMed ID: 10554090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels.
    Schleifer KJ; Tot E
    J Comput Aided Mol Des; 2000 Jul; 14(5):427-33. PubMed ID: 10896315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary biological evaluation of 4,6-disubstituted 3-cyanopyridin-2(1H)-ones, a new class of calcium entry blockers.
    Manna F; Chimenti F; Bolasco A; Bizzarri B; Botta M; Tafi A; Filippelli A; Rossi S
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1883-5. PubMed ID: 10969991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.
    Das J; Floyd DM; Kimball SD; Duff KJ; Lago MW; Krapcho J; White RE; Ridgewell RE; Obermeier MT; Moreland S
    J Med Chem; 1992 Jul; 35(14):2610-7. PubMed ID: 1635059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clentiazem and diltiazem preserve endothelium-dependent relaxation following global rat heart ischemia.
    Dagenais F; Hollmann C; Buluran J; Cartier R
    Can J Cardiol; 1995 Oct; 11(9):816-22. PubMed ID: 7585280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effect of a calcium channel blocker, Diltiazem, on the ischemic-reperfused heart.
    Weishaar RE; Bing RJ
    J Mol Cell Cardiol; 1980 Oct; 12(10):993-1009. PubMed ID: 6257916
    [No Abstract]   [Full Text] [Related]  

  • 17. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
    Nearing BD; Hutter JJ; Verrier RL
    J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers.
    Tanonaka K; Kajiwara H; Kameda H; Takasaki A; Takeo S
    Eur J Pharmacol; 1999 May; 372(1):37-48. PubMed ID: 10374713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 1. Antinecrotic and antiarrhythmic effects in reperfused rat hearts.
    Masui M; Funakawa S; Uno O; Mihara S; Takahara Y; Matsunaga K; Iwaki K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):526-32. PubMed ID: 8891877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
    Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.